Dr. Wolpaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-590-2204
Education & Training
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2012 - 2015
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2012
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- PA State Medical License 2012 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.Liron D Grossmann, Chia-Hui Chen, Yasin Uzun, Anusha Thadi, Adam J Wolpaw
Cancer Discovery. 2024-12-02 - 1 citationsCAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma.Guillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, Anna M Giudice, Laura Garcia-Gerique
Nature Communications. 2024-08-21 - 4 citationsCell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity.Xue Zhang, Shishir M Pant, Cecily C Ritch, Hsin-Yao Tang, Hongguang Shao
Nature Communications. 2024-01-20
Press Mentions
- Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and SignalingFebruary 8th, 2022
- Potential Tumor Vulnerability May Be Exploited to Improve Treatment of NeuroblastomaFebruary 7th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: